More recent work, including a 2025 study evaluating a different experimental lateral-flow POC IgM test, suggests that newer technologies may achieve high diagnostic performance with sensitivities in the 88–92% range and specificities of 96–98% when compared to a composite reference comparator and clinical CS categories (16,17). Here, CD40LG is linked to Cowden syndrome 1.